Molecular imaging and therapy - A programme based on the development of new biomolecules

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 12, 2005, Pages 1354-1359

  Haberkorn, Uwe ^a   Eisenhut, Michael ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; DEOXYRIBOZYME; LIGAND; NUCLEIC ACID; RIBOZYME;

BIOINFORMATICS; COMPUTER ASSISTED TOMOGRAPHY; CONFORMATION; DISPLAY SYSTEM; DNA RECOMBINATION; DNA SHUFFLING; EDITORIAL; GENE CONTROL; GENETIC VARIABILITY; HUMAN; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; MOLECULAR IMAGING; MOLECULAR LIBRARY; MULTIGENE FAMILY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGE DISPLAY; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REPORTER GENE; SCINTISCANNING; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; SYNTHESIS; THREE DIMENSIONAL IMAGING;

DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE THERAPY; MOLECULAR BIOLOGY; MOLECULAR PROBE TECHNIQUES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 28544440973     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1924-7     Document Type: Editorial

References (31)

1. Wefsissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316-33
2. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80
3. Austin JL. Zen and the brain. Cambridge: MIT Press; 1999
4. Haberkorn U, Altmann A, Eisenhut M. Functional genomics and proteomics - the role of nuclear medicine. Eur J Nucl Med 2002;29:115-32
5. Haberkorn U, Altmann A, Mier W, Eisenhut M. Impact of functional genomics and proteomics on radionuclide imaging. Semin Nucl Med 2004;34:4-22
6. Ryu DDY, Nam DH. Recent progress in biomolecular engineering. Biotechnol Prog 2000;16:2-16
7. Wong D, Robertson G. Applying combinatorial chemistry and biology to food research. J Agric Food Chem 2004;52:7187-98
8. Smithgall TE. SH2 and SH3 domains: potential targets for anti-cancer drug design. J Pharmacol Toxicol Methods 1995;34:125-32
9. Gaisser S, Kellenberger L, Kaja A, Weston AJ, Lill RE, Wirtz G, et al. Direct production of avermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272. Org Biomol Chem 2003;1:2840-7
10. Hecht MH, Das A, Go A, Bradley LH, Wei Y. De novo proteins from designed combinatorial libraries. Protein Sci 2004;13:1711-23
11. Dennett DC. Darwin's dangerous idea. New York: Simon and Schuster; 1995
12. Stemmer WPC. Rapid evolution of protein in vitro by DNA shuffling. Nature 1994;370:389-91
13. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1315-7
14. Smith GP, Petrenko VA. Phage display. Chem Rev 1997;97:391-410
15. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, et al. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 1999;17:768-74
16. Pasqualini R. Vascular targeting with phage peptide libraries. Q J Nucl Med 1999;43:159-62
17. Burg MA, Pasqualini R, Arap W, Ruoslahti E, Stallcup WB. NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res 1999;59:2869-74
18. Oyama T, Sykes KF, Samli KN, Minna JD, Johnston SA, Brown KC. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett 2003;202:219-30
19. Zitzmann S, Krämer S, Mier W, Mahmut M, Fleig J, Altmann A, et al. Identification of a new prostate specific cyclic peptide with the bacterial FLITRX system. J Nucl Med 2005;46:782-5
20. Zitzmann S, Mier W, Schad A, Kinscherf R, Askoxylakis V, Krämer S, et al. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clin Cancer Res 2005;11:139-46
21. Mattheakis LC, Bhatt RR, Dower WJ. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci U S A 1994;91:9022-6
22. Lipovseka D, Plueckthun A. In-vitro protein evolution by ribosome display and mRNA display. J Immunol Methods 2004;290:51-67
23. Hanes J, Schaffitzel C, Knappik A, Plückthun A. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat Biotechnol 2000;18:1287-92
24. Roberts RW, Szostak JW. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci U S A 1997;94:12297-302
25. Keefe AD, Szostak JW. Functional proteins from a random-sequence library. Nature 2001;410:715-8
26. Mathonet P, Fastrez J. Engineering of non-natural receptors. Curr Opin Struct Biol 2004;14:505-11
27. Xu LH, Aha P, Gu K, Kuimelis RG, Lam T, Lim AC, et al. Directed evolution of high affinity antibody mimics using mRNA display. Chem Biol 2002;9:933-42
28. Baggio R, Burgstaller P, Hale SP, Putney AR, Lane M, Lipovsek D, et al. Identification of epitope-like consensus motifs using mRNA display. J Mol Recognit 2002;15:126-34
29. Binz HK, Stumpp MT, Forrer P, Amstutz P, Plückthun A. Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J Mol Biol 2003;332:489-503
30. Ronald R. Breaker natural and engineered nucleic acids as tools to explore biology. Nature 2004;432:838-45
31. Suess B, Fink B, Berens C, Stenz R, Hillen W. A theophylline responsive riboswitch based on helix slipping controls gene expression in vivo. Nucleic Acids Res 2004;32:1610-4